Medication info
Tagamet Tablets 400 Milligrams (Cimetidine)

Tagamet Tablets 400 Milligrams (Cimetidine)

Prescription medicationTabletOral
Ingredient · strength
Cimetidine›400mg / 1 tablet
Manufacturer / importer
(Stock Company) Yuhan Corporation
Appearance
White to pale green oval film-coated tablet
Packaging
100 tablets/bottle, 30 tablets/bottle
Approval status
Active

MFDS item code 198401252 · Notified 1984.04.23 · Insurance code 642104990

Summary

Main use
Treats acid-related disorders (ulcers, reflux esophagitis, etc.) and improves gastric mucosal lesions associated with gastritis
Who takes it
Adults · Children
Adult dose
Adults: Administer 400 mg of cimetidine orally twice daily (in the morning and at bedtime), or 800 mg once daily (at bedtime). Alternatively, administer 300 mg orally 4 times daily (after meals and at bedtime). The dose may be increased to 400 mg per dose 4 times daily (after meals and at bedtime) (total 1.6 g). However, for improvement of gastric mucosal lesions (erosion, bleeding, redness, and edema) in the following conditions—acute gastritis and the acute exacerbation phase of chronic gastritis—administer 200 mg per dose twice daily or 400 mg once daily. An antacid may be administered as needed for pain relief. The dose may be increased in some patients; in such cases, increase the frequency of administration rather than the dose per administration. Do not exceed 2.4 g per day. Patients with renal impairment: Administer 300 mg of this medicine per dose twice daily, every 12 hours. If necessary according to the patient's symptoms, the frequency may be increased to 3 times daily, every 8 hours, or more often, but use caution. In patients with severe renal impairment, the medicine may accumulate in the body; therefore, reduce the frequency of administration to a minimum according to the patient's response. Hemodialysis lowers blood cimetidine levels. After hemodialysis is completed, readminister the medicine according to the schedule. Adjust the dose as appropriate according to age and symptoms.
Child dose
Children: Administer 20 〜 40 mg per kg of body weight per day orally in divided doses.

Ingredients

Manufacturer
(Stock Company) Yuhan Corporation

Efficacy & effects

Treats acid-related disorders (ulcers, reflux esophagitis, etc.) and improves gastric mucosal lesions associated with gastritis

  • Gastric ulcer
  • duodenal ulcer
  • gastroesophageal reflux disease
  • recurrent ulcer
  • anastomotic ulcer
  • Zollinger-Ellison syndrome
  • mucosal lesions
  • erosion
  • bleeding
  • redness
  • swelling
  • acute gastritis
View approved original text

This medication is used for various gastrointestinal disorders such as gastric and duodenal ulcers, gastroesophageal reflux disease, recurrent ulcers, anastomotic ulcers, and Zollinger-Ellison syndrome. It also helps improve symptoms such as erosion, bleeding, redness, and swelling, which are mucosal lesions occurring during acute exacerbation of acute and chronic gastritis. Therefore, this drug effectively acts on treating and alleviating symptoms of various gastrointestinal conditions.

How to take

Adult dose

Adults: Administer 400 mg of cimetidine orally twice daily (in the morning and at bedtime), or 800 mg once daily (at bedtime). Alternatively, administer 300 mg orally 4 times daily (after meals and at bedtime). The dose may be increased to 400 mg per dose 4 times daily (after meals and at bedtime) (total 1.6 g). However, for improvement of gastric mucosal lesions (erosion, bleeding, redness, and edema) in the following conditions—acute gastritis and the acute exacerbation phase of chronic gastritis—administer 200 mg per dose twice daily or 400 mg once daily. An antacid may be administered as needed for pain relief. The dose may be increased in some patients; in such cases, increase the frequency of administration rather than the dose per administration. Do not exceed 2.4 g per day. Patients with renal impairment: Administer 300 mg of this medicine per dose twice daily, every 12 hours. If necessary according to the patient's symptoms, the frequency may be increased to 3 times daily, every 8 hours, or more often, but use caution. In patients with severe renal impairment, the medicine may accumulate in the body; therefore, reduce the frequency of administration to a minimum according to the patient's response. Hemodialysis lowers blood cimetidine levels. After hemodialysis is completed, readminister the medicine according to the schedule. Adjust the dose as appropriate according to age and symptoms.

Child dose

Children: Administer 20 〜 40 mg per kg of body weight per day orally in divided doses.

Precautions

This drug can have glass fragments mixed in when using glass ampules, so care must be taken when cutting the container. Special caution is particularly necessary when used in children or the elderly. Patients with hypersensitivity to this drug or a history of such reactions, as well as those with certain heart diseases, should not use this medication. Patients with impaired renal or liver function, a history of drug allergies, the elderly, children under 19, or patients undergoing hemodialysis should exercise special caution when using this drug. This medication may hide symptoms of gastric cancer, so it is advisable to administer it only after confirming malignancy. Patients with Helicobacter pylori infection and gastric or duodenal ulcers should undergo eradication therapy. This medication can cause various side effects, including blood cell reduction, liver dysfunction, kidney problems, allergic reactions, hormonal changes, digestive disturbances, neurological issues, cardiac rhythm problems, and skin reactions. Should any of these symptoms occur, notify medical personnel immediately, and discontinue use if necessary, seeking appropriate treatment. This drug should be used at the minimum dose while closely monitoring the progression of the disease, and if ineffective, a switch to other treatment options should be made. Particularly in the elderly or patients with a history of peptic ulcer disease, regular monitoring of condition is essential. As this medication interacts with many other drugs, inform healthcare providers if there are concurrent medications, as dosage adjustments or discontinuation may be necessary. Pregnant women or those who may become pregnant should carefully consider the risks and benefits of using this drug, and breastfeeding should be discontinued if using this medication. In children, safety has not been sufficiently established, so it should only be used when absolutely necessary. The elderly may experience increased drug concentration due to decreased renal function, requiring adjustments in dosage or administration intervals. In case of overdose, serious symptoms such as respiratory depression may occur, requiring immediate emergency treatment. When administered as an injection, avoid rapid intravenous administration and administer slowly to minimize side effects. Store out of reach of children and do not transfer to another container to maintain safety and quality.

Side effects

  • Leukopenia
  • neutropenia
  • agranulocytosis
  • thrombocytopenia
  • pancytopenia
  • aplastic anemia
  • generalized weakness
  • asthenia
  • subcutaneous hemorrhage
  • mucosal hemorrhage
Show 57 more
  • fever
  • immune hemolytic anemia
  • jaundice
  • hepatitis
  • elevation of AST
  • elevation of ALT
  • liver dysfunction
  • portal fibrosis
  • interstitial convulsions
  • acute renal failure
  • interstitial nephritis
  • urinary retention
  • elevated BUN
  • shock
  • anaphylactoid reaction
  • hypersensitivity vasculitis
  • rash
  • gynecomastia
  • galactorrhea
  • increased vaginal discharge
  • erectile dysfunction
  • abdominal distension
  • constipation
  • diarrhea
  • headache
  • dizziness
  • convulsions
  • limb paresthesia
  • stiffness
  • drowsiness
  • hypochondriacal symptoms
  • altered consciousness
  • confusional state
  • agitation
  • psychosis
  • depression
  • excitement
  • hallucinations
  • loss of orientation
  • bradycardia
  • tachycardia
  • palpitations
  • atrioventricular block
  • skin and mucosal syndrome
  • toxic epidermal necrolysis
  • epidermal necrosis
  • erythema multiforme
  • exfoliative dermatitis
  • generalized exfoliative erythema
  • fatigue
  • generalized warmth
  • dysuria
  • myalgia
  • arthralgia
  • pancreatitis
  • hair loss
  • polymyositis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air ingress and should be kept at room temperature between 1 and 30 degrees Celsius. Storing it this way can help maintain the drug's effectiveness for a long time.

Appearance and packaging

Appearance

White to pale green oval film-coated tablet

Package unit

100 tablets/bottle, 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.